Keros Therapeutics OverviewKeros Therapeutics Net Income
Profitability analysis for KROS.
Quarterly Net Income
-$23.71M
↓ 115.97% YoY
As of Mar 2026
Annual Net Income (TTM)
-$85.14M
↓ 2121.49% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...